These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30338511)

  • 21. A prospective study on the relationship between polycystic ovary syndrome and age at natural menopause.
    Amiri M; Rahmati M; Firouzi F; Azizi F; Ramezani Tehran F
    Menopause; 2024 Feb; 31(2):130-137. PubMed ID: 38411437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
    Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression.
    Amiri M; Ramezani Tehrani F; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
    Reprod Biol Endocrinol; 2020 Mar; 18(1):23. PubMed ID: 32183820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.
    Mejia-Montilla J; Álvarez-Mon M; Reyna-Villasmil E; Torres-Cepeda D; Santos-Bolívar J; Reyna-Villasmil N; Suarez-Torres I; Bravo-Henríquez A
    Endocrinol Nutr; 2015 Jan; 62(1):31-7. PubMed ID: 25458401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Ramezani Tehrani F; Amiri M; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
    Gynecol Endocrinol; 2020 Jan; 36(1):12-23. PubMed ID: 31385729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health.
    Joham AE; Boyle JA; Ranasinha S; Zoungas S; Teede HJ
    Hum Reprod; 2014 Apr; 29(4):802-8. PubMed ID: 24549213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS.
    Carmina E; Napoli N; Longo RA; Rini GB; Lobo RA
    Eur J Endocrinol; 2006 Jan; 154(1):141-5. PubMed ID: 16382003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone Levels in Third Trimester in Polycystic Ovary Syndrome: Odense Child Cohort.
    Glintborg D; Jensen RC; Bentsen K; Schmedes AV; Brandslund I; Kyhl HB; Bilenberg N; Andersen MS
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3819-3827. PubMed ID: 30060213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.
    Mumm H; Jensen DM; Sørensen JA; Andersen LL; Ravn P; Andersen M; Glintborg D
    Acta Obstet Gynecol Scand; 2015 Feb; 94(2):204-11. PubMed ID: 25417943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.
    Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M
    Cardiovasc Diabetol; 2018 Mar; 17(1):37. PubMed ID: 29519249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S; Ruan J; Huang W; Tan J; Zhang X; Feng X; Liu D; Fu J; Zhou L; Zhou M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy and neonatal complications in women with polycystic ovary syndrome in relation to second-trimester anti-Müllerian hormone levels.
    Valdimarsdottir R; Valgeirsdottir H; Wikström AK; Kallak TK; Elenis E; Axelsson O; Ubhayasekhera K; Bergquist J; Piltonen TT; Pigny P; Giacobini P; Poromaa IS
    Reprod Biomed Online; 2019 Jul; 39(1):141-148. PubMed ID: 31036431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of polycystic ovary syndrome in unselected women from southern China.
    Chen X; Yang D; Mo Y; Li L; Chen Y; Huang Y
    Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):59-64. PubMed ID: 18378061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fracture Risk Is Decreased in Women With Polycystic Ovary Syndrome: A Register-Based and Population-Based Cohort Study.
    Rubin KH; Glintborg D; Nybo M; Andersen M; Abrahamsen B
    J Bone Miner Res; 2016 Apr; 31(4):709-17. PubMed ID: 26542642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, clinical characteristics, and reproductive outcomes of polycystic ovary syndrome in older women referred for tertiary fertility care.
    Tannus S; Tan J; Son WY; Dahan MH
    Arch Gynecol Obstet; 2018 Apr; 297(4):1037-1042. PubMed ID: 29289990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.